Like MDSCs, TAMs also reduce the proliferation of anti-tumor cytotoxic T-cells while promoting regulatory CD4+ T-cell growth by expressing PD-L1 on their surface, secreting TGF-β and IL-10, and producing nitric oxide and arginase. The gene discussed is CD274; the disease is neoplasm.